Accéder au contenu
Merck

Maternal choline concentrations during pregnancy and choline-related genetic variants as risk factors for neural tube defects.

The American journal of clinical nutrition (2014-09-23)
James L Mills, Ruzong Fan, Lawrence C Brody, Aiyi Liu, Per M Ueland, Yifan Wang, Peadar N Kirke, Barry Shane, Anne M Molloy
RÉSUMÉ

Low maternal choline intake and blood concentration may be risk factors for having a child with a neural tube defect (NTD); however, the data are inconsistent. This is an important question to resolve because choline, if taken periconceptionally, might add to the protective effect currently being achieved by folic acid. We examined the relation between NTDs, choline status, and genetic polymorphisms reported to influence de novo choline synthesis to investigate claims that taking choline periconceptionally could reduce NTD rates. Two study groups of pregnant women were investigated: women who had a current NTD-affected pregnancy (AP; n = 71) and unaffected controls (n = 214) and women who had an NTD in another pregnancy but not in the current pregnancy [nonaffected pregnancy (NAP); n = 98] and unaffected controls (n = 386). Blood samples to measure betaine and total choline concentrations and single nucleotide polymorphisms related to choline metabolism were collected at their first prenatal visit. Mean (±SD) plasma total choline concentrations in the AP (2.8 ± 1.0 mmol/L) and control (2.9 ± 0.9 mmol/L) groups did not differ significantly. Betaine concentrations were not significantly different between the 2 groups. Total choline and betaine in the NAP group did not differ from controls. Cases were significantly more likely to have the G allele of phosphatidylethanolamine-N-methyltransferase (PEMT; V175M, +5465 G>A) rs7946 (P = 0.02). Our results indicate that maternal betaine and choline concentrations are not strongly associated with NTD risk. The association between PEMT rs7946 and NTDs requires confirmation. The addition of choline to folic acid supplements may not further reduce NTD risk.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Chlorure de choline, ≥98%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Bétaïne solution, 5 M, PCR Reagent
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Bétaïne, BioUltra, ≥99.0% (NT)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Folic acid, ≥97%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Chlorure de choline, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Folic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥97%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Bétaïne, ≥98% (perchloric acid titration)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Chlorure de choline, ≥99%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Betaine hydrochloride, ≥99%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Chlorure de choline, BioUltra, ≥99.0% (AT)
Référence
Conditionnement
Disponibilité
Prix
Quantité
USP
Folic acid, United States Pharmacopeia (USP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
USP
Chlorure de choline, United States Pharmacopeia (USP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Folic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Folic acid, meets USP testing specifications
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Chlorure de choline, Pharmaceutical Secondary Standard; Certified Reference Material
Référence
Conditionnement
Disponibilité
Prix
Quantité
Folic acid, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité